Pular para o conteúdo principal
Ranking Invest

MTLS - Materialise N.V.

Segmento: TechnologyMaterialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. Its Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. The company's Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. Its Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.

Análise Ranking Invest

Valuation estimado
$ 286.91 Mi
Valor de Mercado
$ 436.07 Mi
Sobrepreço (AV)+52.0%
IVR
0.66A companhia vale 0,66 vezes o seu valor de mercado atual de acordo com a estimativa do Ranking Invest.
IVR2
0.07O valuation alternativo equivale a 7% do valor de mercado da companhia.
MLL
0.07O lucro líquido dos controladores em 16 trimestres equivale a 7% do valor de mercado.
Último Balanço Atualizado: 1T2025

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 248.87 Mi

Dívida Líquida

-$ 67.74 Mi

L4T

$ 9.58 Mi

MM4T

3.52%

Indicadores Básicos

ROE

3.85%

Índices de Previsibilidade

Receita Líquida

B0.04

Lucro

E1.14

Margem

E1.18

Índices de Tendência

Receita Líquida

A10.60

Lucro

E-2.40

Margem

E-3.43

Índices de Endividamento

DIV/PAT

-0.27

DIV/L4T

-7.07

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.